Globus Medical (GMED) Sees IPO Price of $16-$18/Share
Tweet
Share
E-mailGet Alerts GMED Hot Sheet
Up)Join SI Premium – FREE
In an amended S-1 filing Tuesday, Globus Medical (NYSE: GMED) disclosed it will offer 11,764,705 shares at a price ranging from $16-$18 per share. Globus plans to list on the New York Stock Exchange under the ticker, "GMED."
The offering is being made through BofA Merrill Lynch, Goldman, Sachs & Co., Piper Jaffray, Leerink Swann, Canaccord Genuity, William Blair & Company, and Oppenheimer & Co.
Globus Medical a medical device company focused exclusively on the design, development and commercialization of products that promote healing in patients with spine disorders.
The offering is being made through BofA Merrill Lynch, Goldman, Sachs & Co., Piper Jaffray, Leerink Swann, Canaccord Genuity, William Blair & Company, and Oppenheimer & Co.
Globus Medical a medical device company focused exclusively on the design, development and commercialization of products that promote healing in patients with spine disorders.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- William Blair Starts First Advantage (FA) at Outperform, 'Best-in-Class Background Screener'
- Globus Medical Schedules First Quarter Earnings Release and Conference Call
- William Blair on Sage Therapeutics (SAGE): 'we have difficulty envisioning what additional data could be generated to support a resubmission'
Create E-mail Alert Related Categories
IPOsRelated Entities
Piper Jaffray, William Blair, S1, Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
